Last reviewed · How we verify
NCT05898334
Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery
NA trial testing Active Biophoton Generators in Chronic Stroke in 48 participants. Completed in 28 June 2024.
28 June 2024
Quick facts
| Lead sponsor | First Institute of All Medicines |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 10 May 2023 |
| Primary completion | 28 June 2024 |
| Estimated completion | 28 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Active Biophoton Generators
- Inactive Biophoton Generators
Conditions studied
- Chronic Stroke — all drugs for Chronic Stroke →
- Paralysis — all drugs for Paralysis →
Sponsor
First Institute of All Medicines
Who can join
Adults 18 to 80, any sex, with Chronic Stroke or Paralysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this clinical research is to verify if the patients with chronic stroke can regain the ability of living independently after daily using Testa BioHealing® Biophoton Generators to increase the energy of the brain and other parts of the body. The main study questions are: * Can patients with chronic stroke regain life independence by normalizing Activities of Daily Living (ADL). * Can brain-injury and recovery status of the patients with chronic stroke be detected by using an EEG machine. Participants will sleep-rest on a hotel bed energized by Tesla BioHealing Biophoton Generators, and clinical study staff will observe the participant's activities of daily living, as compared to those who will sleep in the hotel room equipped with placebo devices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05898334
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Stroke
Currently open trials in the same condition.
- NCT07468110 — Evaluation Of The Relationship Between The Conut Score And Balance And Functional Status In Patients With Chronic Stroke · recruiting
- NCT07378774 — Constraint Induced Movement Therapy and Bilateral Training in Chronic Stroke · NA · recruiting
- NCT07353203 — Safety and Efficacy of Hip Assist Powered Exoskeleton for Gait Training in Patients With Late Subacute and Chronic Strok · NA · recruiting
- NCT07065292 — Plantar Sensation, Position Sense, and Weight-Bearing Asymmetry Related to Balance and Mobility Post-Stroke · recruiting
- NCT06286800 — Personalized Transcranial Direct Current Stimulation in Stroke Recovery · NA · recruiting
Other First Institute of All Medicines trials
Trials by the same sponsor.
- NCT07124208 — A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Dia · NA · recruiting
- NCT06915012 — Impact of Biophoton Therapy on Chronic Severe Arthritis Pain · NA · recruiting
- NCT06855459 — The Impact of Biophoton Therapy on Self-Grown Stem Cells · NA · recruiting
- NCT06147999 — Impact of a Biophoton Therapy on Patients With Brain Disorders · NA · recruiting
- NCT06049849 — Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05898334 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First Institute of All Medicines
- Last refreshed: 1 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05898334.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing